New bioterror response research institute opens near Washington, D.C.

Monday, Nov 16, 2009 @ 4:55pm by BioPrepWatch Reports

The Stanford Research Institute International's new research facility in Harrisonburg, Va., has officially opened after four years of planning and construction.
Read More »

Congressional commission says threat of bioterrorism not being addressed

Monday, Nov 16, 2009 @ 5:01pm by Nick Rees

An interim report by the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism states that the United States has failed to address the threat of bioterrorism.
Read More »

Canadian pathogen labs found to be struggling to keep track of their pathogens

Tuesday, Nov 17, 2009 @ 4:43pm by BioPrepWatch Reports

A recent audit has shown that Canadian government labs handling samples of swine flu and other viruses and bacteria are struggling to keep track of their pathogens.
Read More »

Experimental anthrax treatment denied approval

Tuesday, Nov 17, 2009 @ 4:48pm by Nick Rees

U.S. health regulators have decline to approve a new experimental treatment for anthrax infection from Human Genome Sciences, Inc.
Read More »

Maryland biopharmaceutical company purchases East Baltimore bioscience center

Tuesday, Nov 17, 2009 @ 4:58pm by BioPrepWatch Reports

A Rockville, Maryland based biopharmaceutical company has purchased the East Baltimore bioscience nonprofit MdBio Foundation's 55,000-square-foot BioProcessing Center in East Baltimore.
Read More »

Cell phone sensor aims to crowd source chemical attack information

Tuesday, Nov 17, 2009 @ 5:03pm by Nick Rees

NASA scientists have developed a new chemical sensor that allows iPhones to identify low airborne concentrations of chemicals including ammonia, chlorine gas and methane.
Read More »

Army signs agreement to roll out new biological agent detector

Tuesday, Nov 17, 2009 @ 8:58pm by BioPrepWatch Reports

Defense contractor General Dynamics and the U.S. Army Edgewood Chemical Biological Center have signed an agreement to work in tandem to roll out a new biological agent detector for commercial use.
Read More »

Critics say swine flu reaction shows lack of preparedness for biological attack

Wednesday, Nov 18, 2009 @ 2:47pm by Nick Rees

With H1N1 vaccinations efforts not going as smoothly as planned as lower-than-expected vaccine yields have reduced the number of doses available, questions have been raised about national preparation for biological attacks.
Read More »

Primate research center granted stimulus funds for Marburg and Ebola vaccine study

Wednesday, Nov 18, 2009 @ 2:51pm by BioPrepWatch Reports

Federal stimulus money has been granted to the New England Primate Research Center for investigations and a contract tied to developing a vaccine for the Marburg and Ebola viruses.
Read More »

Handheld sensors used to discretely protect nation's railways

Wednesday, Nov 18, 2009 @ 2:56pm by Nick Rees

Handheld sensors are being utilized by federal agents riding trains throughout the United States to detect biological or radiological materials that could potentially be used in an attack on a major metropolitan area.
Read More »

First ricin antidote moves into production phase

Wednesday, Nov 18, 2009 @ 3:06pm by BioPrepWatch Reports

Scientists at the British government and military park Porton Down have announced the development of an antidote to the poison ricin that they say is ready to be manufactured.
Read More »

James Neal joins XOMA Ltd., to aid in building biodefense programs

Wednesday, Nov 18, 2009 @ 3:13pm by Nick Rees

James R. Neal has joined XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, as vice president of business development.
Read More »

Contract to supply 5 million doses of anthrax vaccine valued at $120 million

Thursday, Nov 19, 2009 @ 3:28pm by BioPrepWatch Reports

Read More »

Emergent BioSolutions acquires advanced anthrax vaccine candidate, technology

Thursday, Nov 19, 2009 @ 3:31pm by BioPrepWatch Reports

Read More »

Human Genome Sciences, Inc. receives approval for anthrax treatment

Thursday, Nov 19, 2009 @ 3:42pm by BioPrepWatch Reports

A Complete Response Letter has been sent to Human Genome Sciences, Inc., from the U.S. Food and Drug Administration about HGS' request for the approval of its treatment for inhalational anthrax.
Read More »

Anthrax drug's effectiveness questioned

Thursday, Nov 19, 2009 @ 3:48pm by Nick Rees

Federal regulators have questioned the effectiveness of Human Genome Sciences, Inc.'s new anthrax treatment raxibacumab.
Read More »

Anthrax drug maker questions approval process for drug

Thursday, Nov 19, 2009 @ 3:50pm by BioPrepWatch Reports

The delay to Human Genome Sciences' experimental anthrax drug appears inconsistent with published final rules governing the development of new drugs by the FDA, an HGS spokesperson has said.
Read More »

Grant goes to Purdue University to fund research into life cycle of potential bioweapon viruses

Thursday, Nov 19, 2009 @ 4:03pm by Nick Rees

The life cycles of two virus types that could be used as biological weapons will be researched with funding from a National Institutes of Health agency with the hope of creating better treatments against them.
Read More »

Danish firm gets U.S. contract for freeze-dried smallpox vaccine

Thursday, Nov 19, 2009 @ 4:10pm by BioPrepWatch Reports

The United States will pay the Danish biotechnology firm Bavarian Nordic as much as $40 million to adopt its smallpox vaccine so that it can be freeze-dried.
Read More »

Funding secured for second New York City protection ring

Friday, Nov 20, 2009 @ 2:15pm by Nick Rees

An antiterrorism system featuring chemical-agent sensors and other high-tech security devices is expected to encircle midtown New York City by 2011.
Read More »